254 related articles for article (PubMed ID: 26137913)
1. Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.
Cui D; Zhang C; Liu B; Shu Y; Du T; Shu D; Wang K; Dai F; Liu Y; Li C; Pan F; Yang Y; Ni J; Li H; Brand-Saberi B; Guo P
Sci Rep; 2015 Jul; 5():10726. PubMed ID: 26137913
[TBL] [Abstract][Full Text] [Related]
2. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
[TBL] [Abstract][Full Text] [Related]
3. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
[TBL] [Abstract][Full Text] [Related]
4. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
[TBL] [Abstract][Full Text] [Related]
5. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
6. BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer.
Wang K; Ruan J; Qian Q; Song H; Bao C; Zhang X; Kong Y; Zhang C; Hu G; Ni J; Cui D
J Nanobiotechnology; 2011 May; 9():23. PubMed ID: 21612621
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse.
Akhtar J; Wang Z; Yu C; Zhang ZP
J Gastroenterol Hepatol; 2014 Sep; 29(9):1685-91. PubMed ID: 24720379
[TBL] [Abstract][Full Text] [Related]
9. [Lentiviral vector-mediated Nanog short-hairpin RNA inhibits the growth of human gastric carcinoma xenograft in nude mice].
Li K; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):18-22. PubMed ID: 25575052
[TBL] [Abstract][Full Text] [Related]
10. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
Guo S; Tschammer N; Mohammed S; Guo P
Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA.
Hao JH; Gu QL; Liu BY; Li JF; Chen XH; Ji YB; Zhu ZG; Lin YZ
Chin Med J (Engl); 2007 Dec; 120(23):2105-11. PubMed ID: 18167184
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth.
Habib R; Akhtar J; Taqi M; Yu C; Zhang C
Oncol Rep; 2015 Aug; 34(2):859-67. PubMed ID: 26043753
[TBL] [Abstract][Full Text] [Related]
13. Short hairpin RNA targeting autotaxin reduces human gastric carcinoma AGS cell proliferative, migratory and invasive capabilities in vitro and causes tumor regression in vivo.
Chen Z; Huang Y; Shen X; Guo J; Zhu G; Dralle H; Hoang-Vu C
Oncol Rep; 2013 Mar; 29(3):1087-93. PubMed ID: 23258351
[TBL] [Abstract][Full Text] [Related]
14. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
Liu P; Wang TS; You SH; Ge HM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
Sun P; Yu H; Zhang WQ; Hu M; Lv R
Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
[TBL] [Abstract][Full Text] [Related]
16. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
[TBL] [Abstract][Full Text] [Related]
17. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
[TBL] [Abstract][Full Text] [Related]
19. PLCĪµ1: a potential target of RNA interference therapy for gastric cancer.
Yan F; Fu Q
Biochem Biophys Res Commun; 2014 Jun; 448(4):409-13. PubMed ID: 24796667
[TBL] [Abstract][Full Text] [Related]
20. Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancer.
Peng H; Yang H; Song L; Zhou Z; Sun J; Du Y; Lu K; Li T; Yin A; Xu J; Wei S
J Exp Clin Cancer Res; 2016 Mar; 35():57. PubMed ID: 27029190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]